Accelerate Diagnostics, Inc - COM (AXDX)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
325K
Holdings value Q2 2024
$381K
Value change Q2 2024
$0
Grand Portfolio weight change Q2 2024
0%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 325K $381K $0 $1.17 1
2024 Q1 325K $322K -$171K $0.99 1
2023 Q4 294K $1.15M -$24.6K $3.92 2
2023 Q3 292K $1.68M -$27.3M $5.75 2
2023 Q2 22.1M $17.9M -$1.7M $0.81 49
2023 Q1 24.5M $17.1M -$721K $0.70 65
2022 Q4 25.5M $18M -$2.28M $0.71 70
2022 Q3 27M $41.1M +$13M $1.52 74
2022 Q2 18.7M $18.5M -$4.81M $0.99 65
2022 Q1 22.6M $32.5M -$3.13M $1.44 92
2021 Q4 23.8M $124M +$1.06M $5.22 101
2021 Q3 23.1M $135M -$6.51M $5.83 102
2021 Q2 24.2M $195M -$4.13M $8.06 93
2021 Q1 24.7M $205M -$24.7M $8.32 100
2020 Q4 27.8M $211M -$14.7M $7.58 112
2020 Q3 29.2M $311M -$5.07M $10.66 113
2020 Q2 29.5M $448M +$4.13M $15.16 121
2020 Q1 29.5M $246M -$8.84M $8.33 106
2019 Q4 30.3M $513M +$10.4M $16.90 104
2019 Q3 29.7M $551M -$3.17M $18.57 114
2019 Q2 29.7M $679M +$50.9M $22.88 115
2019 Q1 27.5M $579M +$584K $21.02 117
2018 Q4 27.7M $318M +$10.1M $11.50 107
2018 Q3 26.7M $612M +$44.7M $22.95 118
2018 Q2 24.7M $551M +$80.3M $22.30 119
2018 Q1 21.2M $484M +$380K $22.85 117
2017 Q4 20.7M $544M -$29.7M $26.20 115
2017 Q3 22.2M $499M +$42.8M $22.45 115
2017 Q2 20.2M $554M +$12.8M $27.35 114
2017 Q1 20.3M $493M +$161M $24.20 96
2016 Q4 15.2M $315M +$13.7M $20.75 106
2016 Q3 14.5M $394M +$29.3M $27.26 101
2016 Q2 13.6M $196M -$4.16M $14.39 93
2016 Q1 13.8M $198M -$7.75M $14.37 90
2015 Q4 13.6M $292M +$71M $21.49 95
2015 Q3 10.4M $168M +$102K $16.18 87
2015 Q2 10.1M $260M +$36.1M $25.81 84
2015 Q1 8.67M $195M +$18.6M $22.50 72
2014 Q4 7.9M $152M +$12.3M $19.19 77
2014 Q3 5.38M $115M +$11.5M $21.48 71
2014 Q2 4.8M $125M -$83.5M $26.00 73
2014 Q1 8.85M $193M +$113M $21.81 55